Reports: Legislative

LDH submits the attached Annual Report prepared in response to ACT 117 (Senate Bill 57) of the 2013 Regular Legislative Session.

In response to HCR 118 of the 2019 Regular Legislative Session the Louisiana Department of Health (LDH) submits the report regarding Ensuring Access to Substance Use Disorder Treatment in Central Louisiana.

In response to HCR 73 of the 2019 Regular Legislative Session the Louisiana Department of Health (LDH) submits the attached report regarding online delivery of certain training required for medication attendants.

In response to ACT 381 of the 2019 Regular Legislative Session, the Louisiana Department of Health submits the report concerning disability service provider rates.

In response to ACT 572 of the 2018 Regular Legislative Session, the Louisiana Department of Health (LDH) submits report on legislatively-mandated reports.

HR 257 of the 2019 regular legislative session requested that the Louisiana Department of Health make changes necessary to eliminate prior authorization requirements in the Medicaid program for all formulations of buprenorphine/naloxone and naltrexone, two medications used for the treatment of opioid use disorder.

The Department of Health submits a detailed monthly report to the Legislature that provides a comprehensive overview of Medicaid spending. The reports include projections for future revenues and expenditures for the given state fiscal year.

In response to House Current Resolution 6 of the 2018 Regular Legislative Session, the Louisiana Department of Health (LDH) submits this quarterly report.

In response to SR 94 of the 2019 Regular Legislative Session, the Louisiana Department of Health submits the Medicaid Mental Health Rehabilitation Service Providers report.